A recent U.S. National Institutes of Health (NIH) clinical trial found for the first time one dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Africa.
The antibody was up to 88.2% effective at preventing infection over 24 weeks, demonstrating that a monoclonal antibody can prevent malaria infection in an endemic region.
The NIH says there is an urgent need for new, fast-acting, infrequently dosed interventions that safely protect against malaria infection.
Malaria Infections Prevented with Monoclonal Antibody
Can Polio Vaccinations Reduce New York's Wastewater Detections
Recent news from the U.S. CDC confirmed wastewater testing had identified circulating polioviruses in at least five New York counties. While there has only been one confirmed vaccine-derived poliovirus type 2 (VDPV2) case, health and political leaders are concerned there may be additional polio cases reported in 2022.
The U.S. CDC Morbidity and Mortality Weekly Report early release issued on October 28, 2022, says public health efforts to prevent polio should focus on improving coverage with the inactivated polio vaccine (IPV).
Pandemic Babies May Face Communication Impairment
But overall neurodevelopment not changed by the COVID-19 pandemic
Infant SARS-CoV-2 Infection Uncommon After In Utero Exposure
All-cause mortality higher for infants born to women with SARS-CoV-2 infection ≤14 days versus >14 days before delivery